Fresenius Medical Care's operating profit surges in Q4
Published by Global Banking & Finance Review®
Posted on February 24, 2026
1 min readLast updated: February 24, 2026
Published by Global Banking & Finance Review®
Posted on February 24, 2026
1 min readLast updated: February 24, 2026
Fresenius Medical Care’s Q4 operating income excluding items jumped 44% to €705m, topping €633m expected. Accelerated cost savings and favorable reimbursement boosted results.
Feb 24 (Reuters) - Fresenius Medical Care reported a sharp rise in fourth‑quarter operating income on Tuesday, helped by accelerating cost savings and favourable reimbursement effects.
Operating income excluding special items jumped 44% to 705 million euros ($830 million), beating analysts' expectations for 633 million euros.
($1 = 0.8497 euros)
(Reporting by Maria Rugamer in Gdansk, editing by Milla Nissi-Prussak)
Fresenius Medical Care’s fourth‑quarter earnings beat. Operating income excluding special items jumped 44% to €705 million, surpassing analyst forecasts and reflecting improved efficiency and reimbursement tailwinds.
Operating income reached €705 million versus €633 million expected, a €72 million beat, driven by accelerated cost savings and favorable reimbursement effects.
Management’s cost‑saving initiatives and favorable reimbursement dynamics. These improved margins and lifted operating income above market expectations.
Explore more articles in the Finance category







